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ABSTRACT Purified integrase protein (EN) can nick linear
viral DNA at a specific site near the ends and integrate nicked
viral DNA into target DNA. We have made a series of 43
site-directed point mutants of human immunodefcency virus
type 2 IN and assayed purified mutant proteins for the follow-
ing activities: site-specific cleavage of viral DNA (donor cut),
integration (strand transfer), and disintegration. In general,
the different activities were similarly affected by the mutations.
We found three mutations that (almost) totally abolished IN
function: Asp-64 -+ Val, Asp-116 -* fle, and Glu-152 -- Leu,
whereas 25 mutations did not affect IN function. A few
mutations affected the different activities differentially. Near
the amino terminus a zinc finger-like sequence motif His-Xaa3-
His-Xaa2,39-Cys-Xaa2-Cys Is present in all retroviral IN pro-
teins. Two mutations in this region (His-12 -* Leu and Cys-40
-+ Ser) strongly inhibited donor cut but had less effect on
strand transfer. The central region of IN is most highly
conserved between retroviral INs. Three mutants in this region
(Asn-117 -I* le, Asn-120 -- Leu, and Lys-159 -+ Val) were
inhibited in strand transfer but were inhibited less strongly in
donor cut. Mutation of Asn-120 (to glycine, leucine, or gluta-
mate) resulted in changes in integration-site preference, sug-
gestng that Asn-120 is involved in interactions with target
DNA. We did not find a mutant in which one activity was lost
and the others were unaffected, supporting the notion that IN
has only one active site for the catalysis of donor cut and strand
transfer.
An important step in the life cycle of all retroviruses is
integration of the viral cDNA into the host-cell genome.
Integration is essential for production of additional viral
particles (1). The integration reaction has been studied in
detail in vitro (2-5). After reverse transcription the integrase
protein (IN; encoded by the 3' one-third of the viral pol gene)
binds to the linear, double-stranded viral DNA. IN removes
a few (usually two) nucleotides from both ends of the viral
cDNA by hydrolysis of the phosphodiester bond 3' of a
conserved CA dinucleotide (6-12). Subsequently the newly
generated viral 3'-hydroxyl DNA ends are transferred to
phosphates in the target DNA. In one concerted reaction the
phosphodiester bond in the target DNA is broken, and a new
one is generated between viral DNA and target DNA (13).
Both ends are integrated in a coordinated fashion, in such a
way that small single-stranded gaps are left between the viral
DNA and host DNA. These gaps are then filled in, probably
by cellular enzymes, resulting in a target-DNA duplication.
Recombinant IN can accomplish several reactions in vitro:
IN mediates (i) site-specific cleavage of double-stranded
DNA molecules that represent the blunt ends of the viral
DNA (donor cut; refs. 6-8, 10, and 11), (ii) integration ofone
viral DNA end into another DNA molecule (strand transfer;
refs. 6, 7, and 14), and (iii) the reverse reaction of integration,
called disintegration (15). The substrate requirements for
cleavage and integration have been determined: a conserved
5'-CA-3' sequence near the end of the DNA is necessary, but
not sufficient, for efficient cleavage and integration (16-18).
Although the substrate requirements of IN are known in
detail, it is not yet clear which parts ofIN are required for the
different steps in the integration reaction. Near the amino
terminus of the 32-kDa IN, a conserved sequence motif is
found: His-Xaa3-His-Xaa20o-Cys-Xaa2-Cys; this has been
referred to as a putative zinc finger (19). There is some
evidence that this region is involved in recognition of specific
long terminal repeat sequences (20). The middle part of the
protein (position 113-162) is most strongly conserved be-
tween retroviral INs and also shows homology to transposase
proteins of bacterial insertion sequences (20, 21). Analysis of
mutant INs revealed amino acids in this region that are
essential for IN activity (22).
We describe here a series of 41 site-directed point mutants
of human immunodeficiency virus type 2 (HIV-2) IN. Most
mutants are equally affected in all three reactions (donor cut,
strand transfer, and disintegration), suggesting that the 32-
kDa IN carries out all these reactions with a single active site.
In a few mutants the different activities were differentially
affected, suggesting that the putative zinc-finger region near
the amino terminus may be primarily required for donor cut
and less for strand transfer and that some amino acids in the
central region (Asn-117, Asn-120, and Lys-159) may primar-
ily play a role in strand transfer. Three mutations (in Asp-64,
Asp-116, and Glu-152) resulted in inactive proteins that
could, however, still bind DNA; any of these might be
involved in catalysis of donor cut and strand transfer.
MATERIALS AND METHODS
DNA Techniques. Standard DNA techniques were done as
described (23). For site-directed mutagenesis the pMa/c
system was used (24). The EcoRI-HindlIl fragment of
pRP279 (25), containing the HIV-2 IN gene under the tran-
scriptional control of the bacteriophage T7 promoter, was
cloned into vector pMc 5-8, resulting in plasmid pRP621.
Heteroduplexes were made of single-stranded DNA of
pRP621 and the EcoRI-HindIII vector fragment ofpMa 5-8.
To create single-site mutants we used oligonucleotides that
introduced the desired triplet into the HIV-2 IN gene. In
addition, a restriction enzyme recognition site was added for
facilitated identification of mutants. The sequences of the
oligonucleotides are available from the authors upon request.
Production, Purition, and Immobization of EflV-2 IN.
Isolation of HIV-2 IN has been described (25). We modified
Abbreviations: HIV, humas mmunodeficiency virus; IN, integrase
protein. Mutants are named as follows: the first letter signifies the
amino acid in the wild-type HIV-2 IN, followed by the position and
the amino acid substituted for the wild-type amino acid.
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this procedure for rapid isolation of small quantities ofmutant
proteins. IN was expressed in Escherichia coli BL21(DE3)
(26), harboring the lysozyme-expressing plasmid pLysS. For
a typical protein isolation IN was extracted from a pellet of
a 50-ml culture, as described (25). The Dounce supernatant
(containing IN) was mixed with 0.5 ml of a 50% (vol/vol)
suspension of butyl-Sepharose 4B (Pharmacia) in Dounce
buffer (20 mM Tris HCl, pH 7.5/1 M NaCl/2 mM dithiothrei-
tol/1 mM EDTA) and incubated for 1 hr. The beads were
washed twice with Dounce buffer and once with Dounce
buffer without dithiothreitol. Proteins were eluted with 0.7 ml
of elution buffer (20 mM Tris HCl, pH 7.5/150 mM NaCl/1
mM EDTA/0.5% Nonidet P-40), and additional protein was
eluted with 0.7 ml of elution buffer with 100mM NaCl instead
of 150 mM. Both elution fractions were mixed, and NaCl was
added to a final concentration of 1 M.
To the protein preparations -1 ,ul of a 50%o suspension of
thiopropyl-Sepharose 6B (Pharmacia) in Dounce buffer with-
out dithiothreitol was added per pmol of IN. The mixture was
stirred for at least 2 hr at 4°C. The beads were washed with
Dounce buffer and twice with 20 mM Mops, pH 7.2/1 mM
dithiothreitol and then resuspended as a 50%o suspension in
this buffer. The immobilized IN was stored at -70°C. Freez-
ing causes a decrease in activity, but once frozen the protein
remains stable (at least for a few months; data not shown).
Assays for IN Activity. The cleavage and integration assay
was done as described (25). Immobilized IN was incubated
for 1 hr at 30°C in a 10-,AI reaction mixture containing 20 mM
Mops (pH 7.2), 25 mM NaCl, 1 mM MnCl2 (or 5 mM MgC12
when indicated), 3 mM dithiothreitol, 0.2 pmol of oligonu-
cleotide substrate (double-stranded 28-mer HIV-2 U5 end;
Fig. 1A), and 3 pmol ofimmobilized IN. The actual HIV-2 U5
DNA end probably has the sequence 5'-CAGGT-3' instead of
5'-CAGG-3' (27). However, we previously showed that the
substrate we used is efficiently cleaved and integrated by
HIV-2 IN (25).
The integration assay was done in the same buffer con-
taining 0.2 pmol ofrecessed HIV-2 U5 end (Fig. 1A, substrate
2). After 15-min incubation at 30°C, 5 pmol of double-
stranded HIV-2 U5 substrate (or, when indicated, of the
randomly chosen oligonucleotide 5'-GCGTGTATGAATC-
CGTCGAGAGCTACTA-3' hybridized to its complementary
strand) was added to provide additional target DNA for
integration, and incubation was continued overnight at 30°C.
Note that we cannot formally exclude that mutant INs that
A
9 AAACCGAGGCAGGAAAATCCCTAGCAGG -3'
TTTGGCTCCGTECCTTTTAGGGATCGTCC -5
2 AAACCGAGGCAGGAAAA'CCCTAGCA -3'
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FIG. 1. (A) Substrates used in cleavage (substrate 1), integration
(substrate 2), and disintegration assays (substrate 3). Position of the
32p label is depicted by a dot. (B) SDS/PAGE analysis of wild-type
HIV-2 IN (lane 1) and mutants D64V, D1161, and E152L (lanes 2-4).
Positions of molecular weight markers (x 1O-3) are indicated at left.
are slower than wild type may reach the same level of
strand-transfer products after this prolonged incubation;
these we would then score as wild type for integration.
The disintegration assay (15) was done under the same
conditions as the cleavage and integration assay. As DNA
substrate 0.2 pmol of a Y-shaped oligonucleotide was used
(Fig. 1A, substrate 3).
RESULTS
Purification and Properties of HIV-2 IN. HIV-2 IN was
expressed in and purified from E. coli. We developed a quick,
small-scale isolation procedure for HIV-2 IN (see Materials
and Methods). The protein was immobilized on the solid-
support thiopropyl-Sepharose. After immobilization, IN can
still cleave viral DNA and mediate strand transfer and
disintegration (Fig. 2 A-C, lane 2). Immobilized HIV-2 IN is
active for 4-8 hr at 30°C, whereas soluble HIV-2 IN loses
most of its activity within 1 hr (data not shown).
Generation and Purification of Mutant Proteins. The HIV-2
IN gene under control of the bacteriophage T7 promoter was
cloned into phasmid vector pMc 5-8. By site-directed muta-
genesis we made 41 mutants in which one triplet was
changed. Most mutations were made in charged or polar
amino acids that are conserved among retroviral INs becaus
they are more likely to be involved in interactions witkDA
than hydrophobic residues, which often have a mQrnorge-
tural function in the protein.
All mutant proteins were isolated in the same way as the
wild-type HIV-2 IN. Five mutants were not soluble in 1 M
NaCl (H16L, C65V, E87L, F121V, and S123L; Table 1). We
conclude that they are probably folding mutants; they were
not further analyzed. Mutant S81A had a lower solubility in
1 M NaCl than wild-type HIV-2 IN. We, therefore, used 10
times more induced E. coli culture for isolation of this mutant
protein. Mutants H12L, C40S, and C43L had a lower affinity
for butyl-Sepharose than wild-type protein. However, we
could obtain a sufficient amount of protein to do the assays.
All other mutants had purification properties similar to wild-
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FIG. 2. Mutational analysis of the amino-terminal region. Cleav-
age (A), integration (B), and disintegration (C) assays of wild-type
(WT) IN (lane 2) and mutants H12L, C40S, and C43L (lanes 3-5). (A
Lower) Shorter exposure of A Upper; B shows integration of
precleaved DNA in an overnight integration reaction with excess
target DNA. (A Upper) Strand transfer that follows donor cut of a
blunt-ended DNA in a 1-hr reaction. Position of28-mer substrate and
26-mer cleavage product in A, 26-mer substrate in B, and 13-mer
substrate and 29-mer disintegration product in C are indicated by
arrows. IP, products resulting from integration of one oligonucleo-
tide into another. Lane 1, without IN.
Biochemistry: van Gent et al.
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Table 1. Point mutants of HIV-2 IN
Mutant* Cl Int Dis Cons Remarks
H12L
-/+ +/- + 5
H16L ND ND ND 5 Insoluble
S39A + + + 3
C40S -/+ + + 5
C43L -/+
-/+ +/- 5
K46L + + + 1
Q53L + + + 1
D64V - - - 5
C65V ND ND ND 1 Insoluble
T66A + + + 5
S81A + + + 5 Low solubility
E87L ND ND ND 1 Insoluble
S93A + + + 5
K103Q + + + 1
R107L + + + 4
H114S + + + 1
T115V + + + 5
D1161 - -/+ - 5
N117I + +/- + 4 Inactive with Mg2+
N120L + +/- + 2 Inactive with Mg2+
F121V ND ND ND 3 Insoluble
S123L ND ND ND 5 Insoluble
K127T + + + 2
P142V + + + 4
Y143L + + + 4
N144V + + + 4
S147A + + + 4
Q148L -/+ -1+ + 2
E152L - - - 5
K159V + +/- + 5 Inactive with Mg2+
R166L + + + 3
K186Q + + + 4
R199S + + + 1
T206A + + + 3
K219N + + + 1
R2281 +/- +/- + 3
K236S + + + 3
K244S + + + 1
K258L + + + 1
R263S + + + 1
R2691 + + + 3
Cl, site-specific cleavage; Int, integration; Dis, disintegration;
Cons, number ofINs in which the amino acid is conserved [out ofthe
following retroviruses: HIV-1, human T-cell leukemia virus type 1,
bovine leukemia virus, Moloney murine leukemia virus, and Rous
sarcoma virus (from ref. 19)]. +, More than 50%o of wild-type level;
+/-, -10-50o of wild-type level; -/+, <10%o of wild-type level;
-, not detectable; ND, not done. Activity levels are estimated from
the autoradiogram. Cleavage is scored negative when the band at the
26-mer position is not stronger than the 27-mer and not much stronger
than the 25-mer.
*The first letter signifies the amino acid in the wild-type HIV-2 IN,
followed by the position and the amino acid substituted for this
amino acid.
type HIV-2 IN. A typical example ofSDS/PAGE analysis of
wild-type and three mutant INs is shown in Fig. 1B.
The Amino-Terminal Region. Near the amino terminus all
retroviral INs have a conserved motifHis-Xaa3-His-Xaa200-
Cys-Xaa2-Cys. This motif somewhat resembles zinc fingers
found in several DNA-binding proteins (19). Zinc fingers are
often involved in specific DNA binding. However, IN does
not have a much higher affinity for specific than for aspecific
DNA (25). We constructed mutants in all four histidine and
cysteine residues. Mutants H12L and C40S are inhibited in
donor cut (Fig. 2A, lanes 3 and 4). However, the strand-
transfer activity of C40S is close to wild type, and H12L is
much less inhibited in strand transfer than in donor cut (Fig.
2B, lanes 3 and 4). Additionally, both mutants mediate
disintegration at wild-type levels (Fig. 2C, lanes 3 and 4).
These results show that His-12 and Cys-40 are important for
donor cut but not so important for strand transfer and
disintegration. Mutant C43L was inhibited in donor cut,
strand transfer, and disintegration (Fig. 2 A-C, lane 5),
suggesting that Cys-43 is important for all IN functions. We
could not assay mutant H16L because this mutant was not
soluble in 1 M NaCl; it probably has an altered structure.
Mutations in two other amino acids, close to both cysteines
(S39A and K46L) resulted in approximately wild-type levels
of donor cut, strand transfer, and disintegration (Table 1).
These results suggest that the putative zinc-finger region is
not involved in catalysis of strand transfer but may play a role
in the correct positioning on viral DNA ends for donor cut.
The differences in purification properties and catalytic ac-
tivities of mutants in these histidine and cysteine residues
indicate that these residues do not have an equivalent role in
a zinc-finger structure, and we consider it unlikely that, in
fact, this is a real zinc-finger domain.
The Central Region. The most strongly conserved region in
retroviral INs is the middle part, approximately from position
113 to 162. This region also shows homology with INs of
retrotransposons and transposases of bacterial insertion se-
quences (20, 21). The most strongly conserved amino acids
are Asp-116 and Glu-152. The amino acids around these two
acidic residues and the spacing between them are also highly
conserved.
Mutant D1161 does not cleave or disintegrate and mediates
strand transfer at a very low level (Fig. 3 A-C, lane 4).
Mutation of Glu-152 results in a protein that is inactive
(E152L in Fig. 3 A-C, lane 8). Mutant Q148L is partially
inhibited (Fig. 3 A-C, lane 7). However, not all conserved
amino acids in this region appear essential for donor cut,
strand transfer, and disintegration in vitro: mutant T115V is
approximately as active as wild-type HIV-2 IN (Fig. 3 A-C,
lane 3). INs containing a mutation in an amino acid located
between the most conserved regions around Asp-116 and
Glu-152 (K127T, P142V, Y143L, N144V, and S147A) show
wild-type levels of activity (Table 1). In all these mutants the
different activities were similarly affected.
We found three mutants in which one activity was more
affected than the other: N117I, N120L, and K159V mediate
the donor cut at nearly wild-type levels (Fig. 3A, lanes 5, 6,
and 9), whereas strand transfer is clearly inhibited in the 1-hr
cleavage and integration reaction. However, in the overnight
integration reaction with precleaved viralDNA the amount of
integration products in the reaction with these mutants is only
slightly less than with wild-type IN (Fig. 3B, lanes 5, 6, and
9). A possible explanation for this phenomenon is that the
amino acids Asn-117, Asn-120, and Lys-159 might be in-
volved in interactions with the target DNA. Interestingly, in
addition to its reduced strand-transfer efficiency, mutant
N120L has a somewhat altered integration-site preference
(compare Fig. 4A, lanes 1 and 2). This mutant also shows a
difference in the pattern of integration products, when a
random double-stranded 28-mer oligonucleotide was used as
integration target instead of HIV-2 U5 ends (compare Fig.
4A, lanes 3 and 4). We also mutated Asn-120 to glycine and
glutamate and found that both mutant proteins showed an
integration-site preference different from the wild-type pro-
tein and mutant N120L (Fig. 4B). These results support the
hypothesis that the region around Asn-120 is involved in
interactions with target DNA. Mutant Q148L, which is
strongly inhibited in both donor-cut and strand transfer, also
seems to have a somewhat different integration-site prefer-
ence (more +2 than +1 product in Fig. 3B, lane 7).
The different activities of some transposases [such as
bacteriophage Mu transposase (28)] are differentially affected
by different divalent cations. Therefore, all cleavage reac-
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FIG. 3. Mutational analysis
of the central region. Cleavage
(A), integration (B), and disinte-
gration (C) assays of wild-type
(WT) IN (lane 2) and mutants
T115V, D1161, N1171, N120L,
Q148L, E152L, and K159V
(lanes 3-9). Composition was as
in Fig. 2.
tions were also assayed with Mg2+ as divalent cation instead
of Mn2+. Wild-type HIV-2 IN cleaves slightly less efficiently
with Mg2+ than with Mn2+, and strand transfer is not carried
out with Mg2+ (data not shown). Like wild-type HIV-2 IN,
most mutants showed a slightly lower cleavage efficiency
with Mg2+ than with Mn2+ as divalent cation. However,
mutants N1171, N120L, and K159V mediate donor cut much
less efficiently with Mg2e than Mn2+ (data not shown).
Other HIV-2 IN Mutants. We also made mutations in the
less conserved parts of the HIV-2 IN gene. Between the
putative zinc finger and the central region we found one
mutant, D64V, that was inactive in all assays (Fig. 5 A-C,
lane 3). Other mutations in this region resulted in wild-type
levels of donor cut, strand transfer, and disintegration (Table
1).
Mutant S81A was less soluble in 1 M NaCl, suggesting that
a (large) proportion of the protein might be incorrectly folded
or unstable. However, the small amount of protein that could
be purified was as active as wild-type HIV-2 IN (Fig. SA, lane
4). In the overnight integration reaction the level of strand
transfer was somewhat lower than wild type (Fig. SB, lane 4),
suggesting that this mutant protein is less stable than wild-
type HIV-2 IN. In addition, the pattern of integration prod-
ucts differs slightly. This difference might be the result of a
small distortion in the protein structure. Alternatively, Ser-81
might play a role in recognition of target DNA. Ser-81 is
certainly not a residue that plays an essential role in donor cut
or strand transfer.
The carboxyl-terminal region is much less conserved be-
tween retroviral INs than the rest of the protein. Most
mutants that contain a single-site mutation in this region are
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FIG. 4. Integration-site preference of mutants in Asn-120. (A)
Integration mediated by mutant N120L. The integration assay was
done with HIV-2 U5 oligonucleotides (lanes 1 and 2) or another
double-stranded 28-mer oligonucleotide (lanes 3 and 4) as integration
target. Integrations were done with wild-type IN (lanes 1 and 3) or
mutant N120L (lanes 2 and 4). (B) Integrations mediated by wild-type
(WT) HIV-2 IN (lane 1) and mutants N120G, N120L, and N120E
(lanes 2-4). HIV-2 US oligonucleotides were used as integration
targets.
as active as wild-type HIV-2 IN (for example, mutant K236S
in Fig. 5 A-C, lane 7; see Table 1). We found one mutation
in this region that reduces donor cut and strand transfer:
R2281 (Fig. 5 A and B, lane 6).
DISCUSSION
We developed a quick isolation method for HIV-2 IN and
used this to screen a large panel of mutants. The method
includes immobilization of (mutant) proteins on a solid sup-
port. We found that, in a qualitative sense, donor cut, strand
transfer, and disintegration are carried out in the same way
by immobilized and soluble IN. However, the higher stability
of immobilized IN enabled us to make the integration assay
more sensitive by prolonged incubation. As a result of
stabilization by immobilization, mutations that cause a lower
protein stability might be scored as wild type in our assays,
whereas they might be considered less active or inactive
when assayed in solution. Not much is known about the
position of IN in the viral-core particle in vivo, but it is
probably not free in solution. Therefore, our assay using
immobilized IN may reflect the in vivo properties of the
protein at least as well as assays with IN in solution. In any
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FIG. 5. Mutational analysis of other regions of HIV-2 IN. Cleav-
age (A), integration (B), and disintegration (C) assays of Ald-type
(WT) IN (lane 2) and mutants D64V, S81A, S93A, R2281, and K236S
(lanes 3-7). Composition was as in Fig. 2.
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case, mutants that have a wild-type level of activity in our
assays are certainly not affected in binding of viral (donor)
DNA, binding of target (acceptor) DNA, or catalytic poten-
tial.
All mutants that did not show wild-type levels of activity
had a similar affinity for DNA and heparin-Sepharose as the
wild-type protein (unpublished results). These observations
indicate that these mutations do not cause severe structural
alterations in the protein (we did at least two independent
isolations of each mutant that showed a decreased activity).
We found two mutants that are inactive in all assays (in amino
acids Asp-64 and Glu-152) and one that is nearly inactive (in
amino acid Asp-116). Therefore, these three amino acids are
candidate active-site residues. These three mutants were the
only ones that did not mediate disintegration.
Ser-85 of Rous sarcoma virus IN, the homolog of Ser-81 in
HIV IN, has been proposed to be an active-site residue (29).
Our results show that mutant S81A, although it is less soluble
and probably less stable than wild-type HIV-2 IN, can
cleave, integrate, and disintegrate. Therefore, this residue is
probably more important for correct folding of the protein
than for catalytic properties.
Another class of mutants is partially inhibited in donor cut
and strand transfer. The amino acids specified by these
mutants might be part of the active site. However, it is also
possible that they inhibit IN action by a small distortion ofthe
protein structure.
More informative mutants are the ones that are more
inhibited in donor cut than in strand transfer (H12L and
C40S) or vice versa (N117I, N120L, and K159V). Both
mutants that are more inhibited in donor cut than in strand
transfer are part of a conserved motif His-Xaa3-His-Xaa20_30-
Cys-Xaa2-Cys near the amino terminus. This motif resembles
zinc fingers that have been found in transcription factors.
Although HIV IN does not have a much higher binding
affinity for specific than for random DNA (16, 25), it is
tempting to speculate that this amino-terminal region is
involved in the correct binding and positioning of the viral
DNA end. For avian sarcoma leukosis virus IN it has also
been shown that mutation of one of the conserved histidine
residues results in a decrease in donor cut (20). Perhaps donor
cut has different substrate requirements than strand transfer
and disintegration. It has already been shown that a Y-shaped
oligonucleotide of random sequence is a substrate in the
disintegration reaction, so this reaction may depend less on
recognition of the viral sequence (15).
Amino acids Asn-117, Asn-120, and Lys-159 play a role in
strand transfer. One explanation for this observation is that
these residues are involved in interactions with the target
DNA. This hypothesis is supported by the changed integra-
tion-site specificity of mutant proteins in which Asn-120 is
changed to glycine, leucine, or glutamate. Asparagine resi-
dues have been shown to be involved in DNA binding (30),
whereas glycine, leucine, and glutamate are normally not
involved in interactions with DNA. These residues could also
be involved in protein-protein interactions, which might be
necessary for strand transfer, but not for donor cut or
disintegration. Mutations at these three positions lead not
only to decreased strand transfer but also to an enhanced
sensitivity for the substitution of Mn2+ by Mg2+ as divalent
cation in the donor cleavage reaction.
Most mutants described here were equally affected in
donor cut, strand transfer, and disintegration, and we did not
find mutants that mediate one activity at wild-type level and
are unable to carry out the other activities. A large fraction
of the conserved polar and charged amino acids have been
mutated. These results suggest that there is only one active
site that can accomplish both hydrolysis of the specific
phosphodiester bond 3' of the conserved CA-3' and the
trans-esterification reaction that results in the actual strand
transfer. The chemistries of the cleavage and strand-transfer
reactions are similar: in the cleavage reaction DNA (in this
case, the two 3' nucleotides) is replaced by water, whereas in
strand transfer the opposite occurs: a new phosphodiester
bond is made, the 3'-OH is replaced by DNA. There are
mutants that are more inhibited in donor cut than in strand
transfer or the reverse, and the effect of divalent cations on
donor cut and strand transfer differs. These results do not
contradict the hypothesis that IN has one active site because
this one active site could still have separate regions for
recognition of the donor and acceptorDNA or, alternatively,
additional domains might be required for strand transfer but
not for the other activities (e.g., a domain that determines IN
dimerization).
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